If you move the decimal to the right once you might be close for this year… lol PLUS shareholders will be given shares on the newly formed Sofpulse ticker sometime later this year.
Company has Nasdaq goals and the valuation will prove the assets value. VA contracts, hospital contracts, and worldwide distribution to come.
I advise listening to NO ONE but yourself when making investment decisions. Don’t listen to me, don’t listen to others on the board.
My hope is that people are savvy enough to have their interest pealed but the discussions both negative and positive and THAT will lead them to further investigate the company based on CURRENT info, employees, structure, and long term viability.
“I’m” confident in my decision and as an investor who’s chooses to support my choice and help spread the word on this company.
Attached is the valuation report done in 2018 for 75 million!! Remember all new developments, models designed, patents, product viability, clinical studies (which several have been done since last valuation) and distribution (have added multiple countries with plans for worldwide) is taking into account. Ocean Tomo is an highly respected industry leader in valuations and has done these for many Nasdaq listed huge companies. Do we think with recent development this goes up or down? My personal guess is UP
I’ve also attached a DD report we originally did on the company that is mostly up to date.
Please don’t listen to anyone but use the info provided to make an educated decision.
News 
Market Data 
Discover 
